$NMTR So NMTR just gave away a full quarter of cash burn for a molecule that has been theorized on mice testing. That is something a deep pocketed pharma can do. Not a pre approval, cash burning biotech. Really hard to understand what's going on here. Ask yourself this. Why was 9 Meters the company that bought the rights? Why weren't other companies interested? And don't tell me NMTR outbid anyone else. Lol!!
3
1
2
2 Likes